Perfluoropropane-albumin microsphere injection

The product obtained new drug certificate in 2006, which is the exclusive variety in China and fills the gap of the second generation ultrasound contrast agent in China. The project has been listed in the “National Technology Innovation Fund for Small and Medium-sized Technological Enterprises” and the “National Development and Reform Commission High-tech Industrialization Demonstration Project”successively. The product is mainly used for patients whose conventional echocardiography is not clear enough. It can enhance the recognition of left ventricular endocardial boundary. At the same time, it has significant application value in clinical diagnosis of fallopian tube, thyroid gland, mammary gland, kidney, liver and other organs.